Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.33 |
| ▸ | OXTR | P30559 | 1/20 | 0.33 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.33 |
| ▸ | PDE6D | O43924 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | USP1 | O94782 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20347842 | 0.85 | PDE6D (0.40) | PDE6DALDH1A1HTTKDM4E | |
| SCHEMBL19654672 | 0.85 | HDAC4 (0.33) | CLK4ADRB2AVPR2OXTRAVPR1A | |
| SCHEMBL20347847 | 0.84 | PDE6D (0.40) | PDE6DALDH1A1KDM4E | |
| SCHEMBL20689873 | 0.83 | ALDH1A1 (0.33) | ALDH1A1HTTHSD17B10 | |
| SCHEMBL21702812 | 0.75 | PDE6D (0.37) | PDE6DALDH1A1KDM4E | |
| SCHEMBL19654661 | 0.73 | ALDH1A1 (0.35) | CLK4ADRB2AVPR2OXTRAVPR1A | |
| SCHEMBL24703330 | 0.73 | NR1H3 (0.39) | ALDH1A1HTT | |
| SCHEMBL20347849 | 0.72 | L3MBTL1 (0.35) | PDE6DALDH1A1KDM4E | |
| SCHEMBL19654692 | 0.72 | HDAC6 (0.51) | CLK4ADRB2AVPR2OXTRAVPR1A | |
| SCHEMBL20347852 | 0.72 | L3MBTL1 (0.37) | PDE6DALDH1A1HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10686139-B2 | Nitrogen-containing compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-16 | — | — | US | disclosed |
| US-20170346017-A1 | NITROGEN-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-20170346017-A1 | NITROGEN-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170346017-A1 | NITROGEN-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | NOM1, NOS1, NPM1 | CLK4 3773/4885ADRB2 3707/4885AVPR2 3240/4885 |
| US-10686139-B2 | Nitrogen-containing compound and organic electroluminescence device including the same | NOM1, NOS1, NPM1 | CLK4 3773/4885ADRB2 3707/4885AVPR2 3240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.